NASDAQ:LIMN | Cash Flow Statement | Liminatus Pharma, Inc.

Complete source-backed cash-flow history.

Available history
2024-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$1.41M
2026-03-31-$1.12M-$2.02M$3.59M
2025-12-31-$8.17M-$386,847.00$0.00$0.00$0.00
2025-09-30-$1.82M
2025-06-30$113,287.00
2025-03-31-$327,526.00-$159,393.00-$575,000.00$713,000.00
2024-12-31-$229,752.00-$140,660.00-$550,000.00$700,000.00
2024-09-30-$601,372.00
2024-06-30-$961,207.00
2024-03-31-$1.75M$0.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$10.21M-$9.96M$13,108.00-$788,108.00$11.03M
2024-12-31-$3.55M-$1.45M-$2.85M$3.92M